Cotazym (Organon) en es it fr

Cotazym (Organon) Brand names, Cotazym (Organon) Analogs

Cotazym (Organon) Brand Names Mixture

  • No information avaliable

Cotazym (Organon) Chemical_Formula


Cotazym (Organon) RX_link

Cotazym (Organon) fda sheet

Cotazym (Organon) msds (material safety sheet)

Cotazym (Organon) Synthesis Reference

No information avaliable

Cotazym (Organon) Molecular Weight


Cotazym (Organon) Melting Point

48-50 oC (Vinogradov, A.A. et al., Protein Eng. 14:683-689 (2001)).

Cotazym (Organon) H2O Solubility

No information avaliable

Cotazym (Organon) State


Cotazym (Organon) LogP

No information avaliable

Cotazym (Organon) Dosage Forms


Cotazym (Organon) Indication

For treatment of cystic fibrosis, chronic pancreatitis, pancreatic duct blockage

Cotazym (Organon) Pharmacology

Used in the treatment of cystic fibrosis or pancreatic dysfunction, pancrelipase helps improve fat digestion in the small intestine. Specifically, the lipase, protease and amylase components break down fat, protein, and starches, respectively, in the small intestine. Lipase hydrolyzes fats into glycerol and fatty acids. Protease converts proteins into proteoses and derived substances, while amylase converts starches into dextrins and sugars. Pancreatic enzymes are used to correct maldigestion, malabsorption and pain associated with pancreatic insufficiency. The major maldigestion/malabsorption problems arise from incomplete fat digestion. Exogenous pancrelipase reduces the amount of nitrogen and fat excreted in the stool.

Cotazym (Organon) Absorption

No information avaliable

Cotazym (Organon) side effects and Toxicity

No information avaliable

Cotazym (Organon) Patient Information

No information avaliable

Cotazym (Organon) Organisms Affected

Humans and other mammals